This is a preview of subscription content, log in via an institution to check access.
References cited
Andersen, K. E., Braestrup, C. B., Gronvald, F. C., Jorgensen, A. S., Nielsen, E. B., Sonnewald, U., Sorensen, P. O., Suzdak, P. D. and Knutsen, L. J. S., The Synthesis of Novel GABA Uptake Inhibitors. 1. Elucidation of the Structure-Activity Studies Leading to the Choice of (R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an Anticonvulsant Drug Candidate.J. Med. Chem., 36, 1716–1725 (1993).
Bornstein, M. R. and Doukas, P. H., Anticonvulsant Activity of Indanylspirosuccinimide Mannich Bases,J. Pharm. Sci., 76, 300–302 (1987).
Brouillette, W. J., Jestkov, V. P., Brown, M. L., Akhatar, M. S., DeLrey, T. M. and Brown, G. B., Bicycloc Hydantoins with a Bridgehead Nitrogen, Comparison of Anticonvulsant Activities with Binding to the Neuronal Voltage-Dependent Sodium Channel.J. Med. Chem., 37, 3289–3293 (1994).
Harvey, R. A. and Champe, P. C.,Lippincott’s illustrated Reviews: Pharmacology, J.B. Lippincott company, 1992, Chap. 15.
Hays, S. J., Rice, M. J., Ortwine, D. F., Johnson, G., Schwarz, R. D., Boyd, D. K., Coperando, L. F., Vartanian, M. G., and Boxer, P. A., Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity.J. Pharm. Sci., 83, 1425–1432 (1994) and references cited therein.
Heckendorn, R., Allgeier, H., Baud, J., Gundenhauser, W. and Angst, C., Synthesis and Binding Properties of 2-Amino-5-phosphono-3-pentenoic acid Photoaffinty Ligands as Probes for the Glutamate Recognition Site of the NMDA Receptor.J. Med. Chem., 36, 3721–3726 (1993).
Itoh, M., Peptide. I. Selective protection of a- or Side chain Carboxyl Groups of Aspartic and Glutamic Acid. A Facile Synthesis of β-Aspartyl and γ-Glutamyl Peptides.Chem. Pharm. Bull., 17, 1679–1686 (1969).
Kohn, H., Sawhney, K. N., Robertson, D. W. and Leander, J. D., Anticonvulsant Properties ofN-substituted α,α-Diamino acid Derivatives.J. Pharm. Sci., 83, 689–691 (1994).
Kohn, H., Sawhney, K. N., Bardel, P., Robertson, D. W. and Leander, J. D., Synthesis and Anticonvulsant Activities of α-Heterocyclic α-Acetamido-N-benzylacetamide Derivatives.J. Med. Chem., 36, 3350–3360 (1993).
Kornet, M. J. Synthesis and Anticonvulsant Evaluation ofN-Aminosuccinimides.J. Pharm. Sci., 73, 405–406 (1984).
N’Goka, V., Schlewer, G., Linget, J. M., Chambon, J. P. and Wermuth, C. G., GABA uptake Inhibitors: Construction of a General Pharmacophore Model and Successful Prediction of a New Representative.,J. Med. Chem., 34, 2547–2557 (1991).
Sandler, S. R. and Karo, W.,Organic Functional Group Preparation, Vol. III, Academic Press, N. Y., 1972, p. 253.
Sun, Z. Y., Kwon, C. H. and Wurpel, N. D., Structure-Activity Study of 5-Substituted 1-Carbobenzoxy-2-iminohydantoins as Potential Anticonvulsant Agents.J. Med. Chem., 37, 2841–2845 (1994) and references cited therein.
Swinyard, E. A., Woodhead, J. H., White, H. S. and Frankline, M. R.,General Principles, Experimental Section, Quantification and Evaluation of Anticonvulsants in Antiepileptic Drugs, 3rd Ed: In Levy, R.,et al (Eds.), Ravan Press, N. Y., 1989, p. 88.
Wilder, B. J.,Seizure disorder-A Pharmacological Approach to Treatment, Raven Press, N.Y., 1985, pp. 23–27.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, J., Choi, J. & Park, M. Synthesis and anticonvulsant evaluation of A series ofN-Cbz-α-aminoglutarimides. Arch. Pharm. Res. 19, 248–250 (1996). https://doi.org/10.1007/BF02976901
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976901